Results of the MMPI-2 test among patients suffer from depressive disorders and organic depressive disorders
Talarowska, M.; Zboralski, K.; Gałecki, P.
Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego 32(189): 159-162
2012
ISSN/ISBN: 1426-9686 PMID: 22568179 Document Number: 656276
The Minnesota Multiphasic Personality Inventory (MMPI) is a psychological tool used in the diagnosis of various disorders and a helpful tool in determining the direction of the planned psychotherapeutic interactions. Is considered as a gold standard for diagnosis. The aim of the study was to compare the MMPI-2 test in patients with depressive disorders and organic depressive disorders. The study involved 79 people (41 women, 38 men), hospitalized in the Department of Adult Psychiatry Medical University of Łódź. The subjects were divided into two groups: patients with depressive disorders (DD, n = 53) and patients with organic depressive disorders (ODD, n = 26). The study used MMPI-2 test. There were no statistically significant differences between the two groups in MMPI-2 test. Patients with DD have obtained higher scores on scales forming 'neurotic triad' (hypochondria, depression, hysteria), on a scale of psychopathy, psychasthenia and each of the five subscales of depression scale. Patients with depressive disorders achieved higher results than patients with depressive disorders in hypochondria, depression, hysteria, psychopathy, psychasthenia, social introversion scale and each of the five subscales of depression scale. Patients with organic depressive disorders in the test MMPI-2 tend to aggravation (unconscious exaggeration of symptoms), and elevated results on a scale of paranoia, schizophrenia, mania and masculinity-femininity.